News

Eli Lilly and Co., the maker of Zepbound and Mounjaro, announced a successful Phase 3 trial for a once-daily GLP-1 pill for ...
Pfizer on Monday announced it is halting development of a daily weight loss pill after one patient experienced a liver injury ...
I ditched carbs, ditched fats, tried any variety of odd combinations from the cabbage diet, or having one sad little packet ...